Nicholas Investment Partners, LP Maxcyte, Inc. Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$3.59 - $6.81 $2.79 Million - $5.29 Million
-776,963 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$5.26 - $10.84 $1.1 Million - $2.27 Million
-209,338 Reduced 21.22%
776,963 $5.43 Million
Q4 2021

Feb 14, 2022
BUY
$8.87 - $12.94 $54,807 - $79,956
6,179 Added 0.63%
986,301 $10.1 Million
Q3 2021

Nov 15, 2021
BUY
$12.21 - $17.2 $12 Million - $16.9 Million
980,122 New
980,122 $12 Million

Others Institutions Holding MXCT

# of Institutions
124
Shares Held
65.6M
Call Options Held
1K
Put Options Held
2K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $418M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email